Literature DB >> 26231202

Hyperglycemia stimulates p62/PKCζ interaction, which mediates NF-κB activation, increased Nox4 expression, and inflammatory cytokine activation in vascular smooth muscle.

Gang Xi1, Xinchun Shen1, Christine Wai1, Caroline K Vilas1, David R Clemmons2.   

Abstract

Hyperglycemia leads to vascular smooth muscle cell (VSMC) dedifferentiation and enhances responses to IGF-I. Prior studies showed that hyperglycemia stimulated NADPH oxidase 4 (Nox4) synthesis, and IGF-I facilitated its recruitment to a signaling complex where it oxidized src, leading to AKT and MAPK activation. To determine the mechanism that led to these changes, we analyzed the roles of p62 (sequestrosome1) and PKCζ. Hyperglycemia induced a 4.9 ± 1.0-fold increase in p62/PKCζ association, and disruption of PKCζ/p62 using a peptide inhibitor or p62 knockdown reduced PKCζ activation (78 ± 6%). 3-Phosphoinoside-dependent protein kinase 1 was also recruited to the p62 complex and directly phosphorylated PKCζ, leading to its activation (3.1 ± 0.4-fold). Subsequently, activated PKCζ phosphorylated p65 rel, which led to increased Nox4 synthesis. Studies in diabetic mice confirmed these findings (6.0 ± 0.4-fold increase in p62/PKCζ) and their disruption of attenuated Nox4 synthesis (76 ± 9% reduction). PKCζ/p62 activation stimulated inflammatory cytokine production and enhanced IGF-I-stimulated VSMC proliferation. These results define the molecular mechanism by which PKCζ is activated in response to hyperglycemia and suggest that this could be a mechanism by which other stimuli such as cytokines or metabolic stress function to stimulate NF-κB activation, thereby altering VSMC sensitivity to IGF-I. © FASEB.

Entities:  

Keywords:  IGF-I; PDK1; TNF-α; diabetes; p65 rel

Mesh:

Substances:

Year:  2015        PMID: 26231202      PMCID: PMC4653052          DOI: 10.1096/fj.15-275453

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  41 in total

1.  High glucose induces renal mesangial cell proliferation and fibronectin expression through JNK/NF-κB/NADPH oxidase/ROS pathway, which is inhibited by resveratrol.

Authors:  Lanyu Zhang; Shanshan Pang; Bo Deng; Lihua Qian; Juan Chen; Junjie Zou; Jiaoyang Zheng; Linghui Yang; Chunyang Zhang; Xiangfang Chen; Zhimin Liu; Yingying Le
Journal:  Int J Biochem Cell Biol       Date:  2012-01-09       Impact factor: 5.085

2.  Glucose activates protein kinase C-zeta /lambda through proline-rich tyrosine kinase-2, extracellular signal-regulated kinase, and phospholipase D: a novel mechanism for activating glucose transporter translocation.

Authors:  G Bandyopadhyay; M P Sajan; Y Kanoh; M L Standaert; M J Quon; B C Reed; I Dikic; R V Farese
Journal:  J Biol Chem       Date:  2001-07-19       Impact factor: 5.157

3.  Mesangial cell NADPH oxidase upregulation in high glucose is protein kinase C dependent and required for collagen IV expression.

Authors:  L Xia; H Wang; H J Goldberg; S Munk; I G Fantus; C I Whiteside
Journal:  Am J Physiol Renal Physiol       Date:  2005-08-30

4.  Activation of IKK by thymosin alpha1 requires the TRAF6 signalling pathway.

Authors:  Ping Zhang; Justin Chan; Ana-Maria Dragoi; Xing Gong; Stanimir Ivanov; Zhi-Wei Li; Tsung-Hsien Chuang; Tsheng Chuang; Cynthia Tuthill; Yinsheng Wan; Michael Karin; Wen-Ming Chu
Journal:  EMBO Rep       Date:  2005-06       Impact factor: 8.807

5.  Recruitment of Nox4 to a plasma membrane scaffold is required for localized reactive oxygen species generation and sustained Src activation in response to insulin-like growth factor-I.

Authors:  Gang Xi; Xin-Chun Shen; Christine Wai; David R Clemmons
Journal:  J Biol Chem       Date:  2013-04-23       Impact factor: 5.157

6.  Structural and biochemical insights into the homotypic PB1-PB1 complex between PKCζ and p62.

Authors:  Jun Ren; Jue Wang; Zhixin Wang; Jiawei Wu
Journal:  Sci China Life Sci       Date:  2013-12-26       Impact factor: 6.038

7.  p66shc negatively regulates insulin-like growth factor I signal transduction via inhibition of p52shc binding to Src homology 2 domain-containing protein tyrosine phosphatase substrate-1 leading to impaired growth factor receptor-bound protein-2 membrane recruitment.

Authors:  Gang Xi; Xinchun Shen; David R Clemmons
Journal:  Mol Endocrinol       Date:  2008-07-07

Review 8.  Protein kinase Czeta (PKCzeta): activation mechanisms and cellular functions.

Authors:  Takaaki Hirai; Kazuhiro Chida
Journal:  J Biochem       Date:  2003-01       Impact factor: 3.387

9.  The adaptor protein p62/SQSTM1 in osteoclast signaling pathways.

Authors:  Stephen McManus; Sophie Roux
Journal:  J Mol Signal       Date:  2012-01-04

10.  Enhanced neointimal hyperplasia and carotid artery remodelling in sequestosome 1 deficient mice.

Authors:  Rika Sugimoto; Eiji Warabi; Satoru Katayanagi; Satoshi Sakai; Junya Uwayama; Toru Yanagawa; Ayaka Watanabe; Harumi Harada; Kiyoshi Kitamura; Noriko Noguchi; Hiroshi Yoshida; Richard C M Siow; Giovanni E Mann; Tetsuro Ishii
Journal:  J Cell Mol Med       Date:  2009-09-24       Impact factor: 5.310

View more
  10 in total

1.  Inhibition of protein kinase C beta phosphorylation activates nuclear factor-kappa B and improves postischemic recovery in type 1 diabetes.

Authors:  Satyanarayana Alleboina; Thomas Wong; Madhu V Singh; Ayotunde O Dokun
Journal:  Exp Biol Med (Maywood)       Date:  2020-04-23

2.  Hyperglycemia induces vascular smooth muscle cell dedifferentiation by suppressing insulin receptor substrate-1-mediated p53/KLF4 complex stabilization.

Authors:  Gang Xi; Xinchun Shen; Christine Wai; Morris F White; David R Clemmons
Journal:  J Biol Chem       Date:  2018-12-21       Impact factor: 5.157

3.  Protein Kinase G Activation Reverses Oxidative Stress and Restores Osteoblast Function and Bone Formation in Male Mice With Type 1 Diabetes.

Authors:  Hema Kalyanaraman; Gerburg Schwaerzer; Ghania Ramdani; Francine Castillo; Brian T Scott; Wolfgang Dillmann; Robert L Sah; Darren E Casteel; Renate B Pilz
Journal:  Diabetes       Date:  2018-01-04       Impact factor: 9.461

Review 4.  IGF-1 and cardiovascular disease.

Authors:  Yusuke Higashi; Sandeep Gautam; Patrick Delafontaine; Sergiy Sukhanov
Journal:  Growth Horm IGF Res       Date:  2019-01-31       Impact factor: 2.372

5.  IRS-1 Functions as a Molecular Scaffold to Coordinate IGF-I/IGFBP-2 Signaling During Osteoblast Differentiation.

Authors:  Gang Xi; Xinchun Shen; Clifford J Rosen; David R Clemmons
Journal:  J Bone Miner Res       Date:  2016-02-20       Impact factor: 6.741

6.  Protein Scaffolds Control Localized Protein Kinase Cζ Activity.

Authors:  Irene S Tobias; Alexandra C Newton
Journal:  J Biol Chem       Date:  2016-05-03       Impact factor: 5.157

7.  Overexpression of steroid receptor coactivators alleviates hyperglycemia-induced endothelial cell injury in rats through activating the PI3K/Akt pathway.

Authors:  Xiao-Juan Quan; Chun-Lian Liang; Ming-Zhu Sun; Lin Zhang; Xiu-Li Li
Journal:  Acta Pharmacol Sin       Date:  2018-08-08       Impact factor: 6.150

8.  p62/SQSTM1 as an oncotarget mediates cisplatin resistance through activating RIP1-NF-κB pathway in human ovarian cancer cells.

Authors:  Xiao-Yu Yan; Yu Zhang; Juan-Juan Zhang; Li-Chao Zhang; Ya-Nan Liu; Yao Wu; Ya-Nan Xue; Sheng-Yao Lu; Jing Su; Lian-Kun Sun
Journal:  Cancer Sci       Date:  2017-06-25       Impact factor: 6.716

9.  Geniposide promotes autophagy to inhibit insulin resistance in HepG2 cells via P62/NF‑κB/GLUT‑4.

Authors:  Hongwei Jiang; Yujin Ma; Junqiang Yan; Jie Liu; Liping Li
Journal:  Mol Med Rep       Date:  2017-09-18       Impact factor: 2.952

10.  Puerarin attenuates diabetic kidney injury through the suppression of NOX4 expression in podocytes.

Authors:  Xueling Li; Weijing Cai; Kyung Lee; Bohan Liu; Yueyi Deng; Yiping Chen; Xianwen Zhang; John Cijiang He; Yifei Zhong
Journal:  Sci Rep       Date:  2017-11-06       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.